Sponges-associated marine bacteria as sources of antimicrobial compounds | ||||
| Novel Research in Microbiology Journal | ||||
| Volume 6, Issue 5, September and October 2022, Page 1742-1767 PDF (763.19 K) | ||||
| Document Type: Review Article | ||||
| DOI: 10.21608/nrmj.2022.267424 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Amal Nasser Alahmari   ; Shahira A. Hassoubah ; Bothaina Ali Alaidaroos
| ||||
| Department of Biological Sciences, Faculty of Sciences, P.O. Box 80203, King Abdulaziz University, Jeddah, Saudi Arabia | ||||
| Abstract | ||||
| Drug-resistant bacteria are considered to be a substantial risk to the public health. In recent years, a significant number of researches have focused on the marine environment as a promising, and underexplored source of compounds with remarkable bioactivities that might contribute to the battle against superbugs. The Red Sea environment is one of the richest and most interesting sources of natural products, which are widely used either in medicinal and/or nutritional fields. Furthermore, several studies have reported that marine sponges and their associated microorganisms; mostly bacteria, are abundant producers of bioactive compounds such as secondary metabolites. This mini-review aimed to discuss tens of secondary metabolites of various chemical classes that were generated by a variety of bacterial phyla associated with marine sponges, including Actinobacteria, Proteobacteria, Firmicutes, Bacteroidetes, and Cyanobacteria. Numerous secondary metabolites with antibacterial or antifungal efficacy have been recovered from marine bacteria derived from sponges; they have been used as potential sources of antimicrobial compounds and might be promising sources that can be exploited in the future for several pharmaceutical purposes. | ||||
| Keywords | ||||
| Marine sponges; Bacteria; Antimicrobial compounds; Secondary metabolites; Actinobacteria; Pharmaceutical purposes | ||||
|
Statistics Article View: 561 PDF Download: 754 |
||||
